Lysyl-histidyl-glycyl-lysyl-histidyl-glycine
Lysyl-histidyl-glycyl-lysyl-histidyl-glycine has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Oct 31, 2026: “In vitro effects of synthetic immunotropic hexapeptides on CD63-CD16+CD62L+CD11b+ and CD63+CD16+CD62L+CD11b+ neutrophilic granulocytes in elderly and senile patients with chronic obstructive…”.
1 new paper in 30 daysSee all 1 papers on lysyl-histidyl-glycyl-lysyl-histidyl-glycine
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
- 1 lab in 1 country
- Cells1
What did studies of lysyl-histidyl-glycyl-lysyl-histidyl-glycine find?
1Studies of lysyl-histidyl-glycyl-lysyl-histidyl-glycine measured one outcome, CD63+CD16brightCD62LbrightCD11bbright neutrophil subset.
CD63+CD16brightCD62LbrightCD11bbright neutrophil subset
downin human cells1
1 study
CD63+CD16brightCD62LbrightCD11bbright neutrophil subset
downin human cells1
Lysyl-histidyl-glycyl-lysyl-histidyl-glycine decreases CD63+CD16brightCD62LbrightCD11bbright neutrophil subset in human cells (chronic obstructive pulmonary disease).
“Incubation with lysyl-histidyl-glycyl-lysyl-histidyl-glycine leads to an increase in the NG subset CD63-CD16brightCD62LbrightCD11bbright, and a decrease in the NG subset CD63+CD16brightCD62LbrightCD11bbright.”
Cellschronic obstructive pulmonary diseaseperipheral blood neutrophilic granulocytes
Russian Journal of Immunology
More on CD63+CD16brightCD62LbrightCD11bbright neutrophil subset